Intended for healthcare professionals

Topical steroid/antibiotic therapy in atopic eczema

Carolyn R Charman
This article reviews the current evidence for use of combined topical steroid/antibiotic preparations in atopic eczema management. Atopic eczema is an inflammatory skin disease which is frequently colonised with Staphylococcus aureus, and may become frankly infected with the organism. S aureus is found in over 90% of areas of clinically involved skin and in 30Ð75% of areas of clinically uninvolved skin, with nasal carriage rates in patients being approximately double that of healthy individuals. In contrast S aureus is found in only 5Ð20% of normal subjects, usually restricted to nasal carriage or low density on the skin. The high colonisation rates in atopic eczema are associated with increased S aureus adherence, which may relate to exposure of receptors, such as fibronectin or alterations in skin pH and lipid composition.
Dermatology in practice 2002; 10(5): 28–30
To continue reading this article, please sign in or register.

Dermatology in practice was previously supported by Wyeth from 2008 to 2010, by Wyeth and Serono in 2007, by Wyeth and Shire from 2005 to 2006, by Medlock Medical in 2004 and by SSL International from 2001 to 2003.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the publisher, Editor or Editorial Board. Accordingly the publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Dermatology in practice is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2021 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to:

ISSN 0262-5504 (Print) ISSN 2049-8446 (Online)